Citations

Citations to this article as recorded by  

• Assessment of novel prognostic biomarkers to predict pathological complete response in patients with non-metastatic triple-negative breast cancer using a window of opportunity design
  Chitradurga Rajashekhar Akshatha, Dhanapathi Halanaik, Rajesh Nachiappa Ganesh, Nanda Kishore, Prasanth Ganesan, Smita Kayal, Harichandra Kumar, Biswajit Dubashi
  Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
• HTA and Gastric Cancer: Evaluating Alternatives in Third- and Fourth-Line Patients
  Lucrezia Ferrario, Federica Asperti, Giuseppe Aprile, Jacopo Giuliani
  International Journal of Environmental Research and Public Health.2023; 20(3): 2107.     CrossRef
• Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
  Tae-Han Kim, In-Ho Kim, Seung Joo Kang, Miyoung Choi, Baek-Hui Kim, Bang Wool Eom, Bum Jun Kim, Byung-Hoon Min, Chang In Choi, Cheol Min Shin, Chung Hyun Tae, Chung sik Gong, Dong Jin Kim, Arthur Eung-Hyuck Cho, Eun Jeong Gong, Geum Jong Song, Hyeon-Su Im
  Journal of Gastric Cancer.2023; 23(1): 3.     CrossRef
• A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines
  Sang Soo Eom, Wonyoung Choi, Bang Wool Eom, Sin Hye Park, Soo Jin Kim, Young Il Kim, Hong Man Yoon, Jong Yeul Lee, Chan Gyoo Kim, Hark Kyun Kim, Myeong-Cherl Kook, Il Ju Choi, Young-Woo Kim, Young Iee Park, Keun Won Ryu
  Journal of Gastric Cancer.2022; 22(1): 3.     CrossRef
• Current therapeutic options for gastric adenocarcinoma
  C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
  Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
• What is the value of third‐line chemotherapy in advanced gastroesophageal cancer? A 5‐year retrospective analysis at a single center
  Justina Yick Ching Lam, Su Pin Choo, David Wai‐Meng Tai, Iain Bee Huat Tan, Chee Kian Tham, Wen Hsin Koo, Simon Yew Kuang Ong, Soo Fan Ang, Clarinda Wei Ling Chua, Dawn Qingqing Chong, Patrick Tze Hern Teo, Christabel Jing Zhi Lee, Samuel Cheng En Ee, Mat
  Asia-Pacific Journal of Clinical Oncology.2020; 16(1): 23.     CrossRef
• Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
  
  Journal of Gastric Cancer.2019; 19(1): 1.     CrossRef
• Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights
  Giandomenico Roviello, Alberto D’Angelo, Raheleh Roudi, Roberto Petrioli, Enrico Mini
  Journal of Oncology.2019; 2019: 1.     CrossRef
• Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study
  In Sil Choi, Mihong Choi, Ju Hyun Lee, Jee Hyun Kim, Koung Jin Suh, Ji Yun Lee, Beodeul Kang, Ji-Won Kim, Se-Hyun Kim, Jin Won Kim, Jeong-Ok Lee, Yu Jung Kim, Soo-Mee Bang, Jong Seok Lee, Keun-Wook Lee, Ju-Seog Lee
  PLOS ONE.2018; 13(6): e0198544.     CrossRef
• The role of third-line chemotherapy in recurrent or metastatic gastric cancer
  Yong Won Choi, Mi Sun Ahn, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Seok Yun Kang, Joon Seong Park, Jin-Hyuk Choi, Seung Soo Sheen
  Medicine.2018; 97(39): e12588.     CrossRef
• Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends
  P. Edwards, M. Davidson, V. Calamai, D. Cunningham, N. Starling
  Cancer Treatment Reviews.2018; 71: 32.     CrossRef
• Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes
  Takashi Nishimura, Satoru Iwasa, Kengo Nagashima, Natsuko Okita, Atsuo Takashima, Yoshitaka Honma, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada, Narikazu Boku
  Gastric Cancer.2017; 20(4): 655.     CrossRef
• Advanced gastric cancer: is there an optimal chemotherapy regimen?
  Kalliopi Andrikou, Massimiliano Salati, Annalisa Fontana, Andrea Spallanzani, Stefania Pipitone, Fabio Gelsomino, Monica Barbolini, Stefano Cascinu
  Expert Review of Quality of Life in Cancer Care.2017; 2(2): 123.     CrossRef
• Third-line systemic treatment versus best supportive care for advanced/metastatic gastric cancer: A systematic review and meta-analysis
  Wing-lok Chan, Kwok-keung Yuen, Steven Wai-kwan Siu, Ka-on Lam, Dora Lai-wan Kwong
  Critical Reviews in Oncology/Hematology.2017; 116: 68.     CrossRef
• Third-line chemotherapy in advanced gastric cancer
  Yu Zheng, Xu-Qing Zhu, Xiao-Gang Ren
  Medicine.2017; 96(24): e6884.     CrossRef
• Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?
  Massimiliano Salati, Katia Di Emidio, Vittoria Tarantino, Stefano Cascinu
  ESMO Open.2017; 2(3): e000206.     CrossRef
• Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy
  Valentina Fanotto, Mario Uccello, Irene Pecora, Lorenza Rimassa, Francesco Leone, Gerardo Rosati, Daniele Santini, Riccardo Giampieri, Samantha Di Donato, Gianluca Tomasello, Nicola Silvestris, Filippo Pietrantonio, Francesca Battaglin, Antonio Avallone,
  The Oncologist.2017; 22(12): 1463.     CrossRef
• Metastatic gastric cancer treatment: Second line and beyond
  Marwan Ghosn, Samer Tabchi, Hampig Raphael Kourie, Mustapha Tehfe
  World Journal of Gastroenterology.2016; 22(11): 3069.     CrossRef
• A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)
  Yoon-Koo Kang, Baek-Yeol Ryoo, Shinkyo Yoon, Lin Shen, Jooyun Lee, Chenlu Wei, Yu Zhou, Min-Hee Ryu
  Cancer Chemotherapy and Pharmacology.2015; 75(2): 309.     CrossRef
• Impact of the availability of active cytotoxic agents on the survival of patients with advanced gastric cancer
  BYUNG HA CHO, HYE SOOK HAN, JIHYUN KWON, JOUNG-HO HAN, SOON MAN YOON, DAE HOON KIM, HYO YUNG YUN, KI HYEONG LEE, SEI JIN YOUN, SEUNG TAIK KIM
  Oncology Letters.2015; 10(4): 2481.     CrossRef
• Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinoma
  Hugo Ford, Ioannis Gounaris
  Therapeutic Advances in Gastroenterology.2015; 8(4): 189.     CrossRef
• Chemotherapy beyond second-line in advanced gastric cancer
  Sung Min Kim
  World Journal of Gastroenterology.2015; 21(29): 8811.     CrossRef
• Biweekly S-1 plus paclitaxel (SPA) as second-line chemotherapy after failure from fluoropyrimidine and platinum in advanced gastric cancer: a phase II study
  Yulong Zheng, Weijia Fang, Chenyu Mao, Joing Qian, Peng Zhao, Xiaochen Zhang, Haiping Jiang, Yi Zheng, Nong Xu
  Cancer Chemotherapy and Pharmacology.2014; 74(3): 503.     CrossRef

The association between a multiple myeloma and a secondary solid tumor is not well established. Some reports showed an increased risk of secondary solid neoplasms in multiple myeloma patients, but others have not. Three cases of the synchronous occurrence of multiple myelomas and solid tumors, namely, a small cell carcinoma of the lung, an adenocarcinoma of the colon and a squamous carcinoma of the pyriform sinus were experienced at our hospital. Therefore, herein is reported the clinical courses and treatment results. The stage of multiple myeloma was Durie-Salmon stage I in all of three cases; therefore, the solid tumors were treated as a primary target because the prognosis of early stage multiple myeloma is generally better than that of advanced solid tumor, while a smoldering or stage I myeloma do not need primary therapy until progression of the multiple myeloma. Two patients died of their solid tumors, but one patient is alive.

Citations

Citations to this article as recorded by  

• Three-year progression-free survival of a patient with concomitant mucinous adenocarcinoma of the colon with peritoneal dissemination and multiple myeloma who received lenalidomide: a case report
  Koki Tamai, Hajime Hirose, Yo Akazawa, Yukihiro Yoshikawa, Masatoshi Nomura, Hiroshi Takeyama, Masahiro Tokunaga, Mitsuyoshi Tei, Shu Okamura, Yusuke Akamaru
  Surgical Case Reports.2024;[Epub]     CrossRef
• The importance of oncological alertness in the differential diagnosis of inflammatory changes in the lungsdetected as a result of differential diagnosis of pneumonia
  M. F. Petrukhnova, O. O. Voronkova, O. E. Buyanova, O. N. Antyufeeva, A. E. Kamalova, M. V. Kozhevnikova, I. S. Ilgisonis, Yu. N. Belenkov
  Meditsinskiy sovet = Medical Council.2024; (9): 100.     CrossRef
• Synchronous multiple myeloma and lung adenocarcinoma: A clinical series
  Fang Ye, Huan Wang, Ningning Li, Aijun Liu, Wenming Chen
  Indian Journal of Pathology and Microbiology.2024; 67(2): 390.     CrossRef
• Simultaneous multiple myeloma and non‑small cell lung carcinoma: A case report and review of the literature
  Huan-Huan Dong, Jing Li, Lin Kang, Qiang Wei, Yan Li
  Oncology Letters.2022;[Epub]     CrossRef
• Rapid progression of gastric cancer with liver metastasis after discontinuation of lenalidomide in a patient with concurrent multiple myeloma: A case report
  Naoto Ujiie, Yoshitaka Enomoto, Naruhito Takido, Yasushi Kawaharada, Masashi Zuguchi, Yosuke Kubota
  International Journal of Surgery Case Reports.2021; 81: 105834.     CrossRef
• Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma
  Wenli Zuo, Xinghu Zhu, Jingke Yang, Zhenyang Mei, Mei Deng, Quande Lin, Yongping Song, Qingsong Yin
  Medicine.2017; 96(1): e5787.     CrossRef
• Drastic Response to Nivolumab in a Case Demonstrating a Rapid Recurrence of Pulmonary Pleomorphic Carcinoma That Developed After Chemotherapy for Comorbid Myeloma Kidney
  Aya Yamamoto, Takashi Iwata, Koji Hashimoto
  Haigan.2017; 57(7): 849.     CrossRef
• Challenges in managing a patient with multiple primary malignancies
  Nataliya Mar, David Askin, Jerry George, Colette Spaccavento, Robert Graham, Lynn Ratner
  Community Oncology.2012; 9(12): 377.     CrossRef
• ¿Asociación entre colangiocarcinoma y mieloma múltiple?
  Laura Gómez-Escolar Viejo, Gema Soler Sala, Vanessa Castaño Giraldo, José María Palazón Azorín, Miguel Pérez-Mateo Regadera
  Gastroenterología y Hepatología.2008; 31(6): 402.     CrossRef
• Synchronous Presentation of Multiple Myeloma and Lung Cancer
  Rishu Agarwal, Ritu Gupta, Archana Bhaskar, Atul Sharma, Sanjay Thulkar, Lalit Kumar
  Journal of Clinical Oncology.2008; 26(35): 5814.     CrossRef

Herein, a case of solitary, unilateral renal metastasis in a patient with curatively resected thoracic esophageal carcinoma, who achieved a pathological complete remission after neoadjuvant concurrent chemoradiotherapy, is reported. The kidney is the 4^th or 5^th most common visceral metastasis site of a primary esophageal carcinoma. More than 50% of renal metastases typically show bilateral involvement. Solitary, unilateral renal metastasis is extremely rare. Renal metastases from a primary esophageal carcinoma are usually latent and its diagnosis is very unusual in a live patient. The solitary renal metastasis in this case was not accompanied by metastases to other sites. The value of a nephrectomy in solitary renal metastasis of esophageal cancer is not known due to the rarity of such cases. A nephrectomy could be justified in limited situations, such as with uncertainty of histological diagnosis, severe life-threatening hematuria, which cannot be controlled by embolization, or solitary renal metastasis with a long disease-free interval.

Citations

Citations to this article as recorded by  

• Rapidly Rising Serum Creatinine in a Patient With Colorectal Adenocarcinoma and Eosinophilia: A Quiz
  Athiphat Banjongjit, Vorachai Ratanatharathorn, Piyanut Mahanupap, Winyou Mitarnun
  American Journal of Kidney Diseases.2024; 83(2): A14.     CrossRef
• Esophageal squamous cell carcinoma metastases to kidney and renal hilar lymph nodes through epithelial-mesenchymal transition: a case report and literature review
  Nai-Jun Fan
  American Journal of Translational Research.2024; 16(5): 1825.     CrossRef
• Secondary Tumors of the Kidney: A Comprehensive Clinicopathologic Analysis
  Faisal Saeed, Adeboye O. Osunkoya
  Advances in Anatomic Pathology.2022; 29(4): 241.     CrossRef
• Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence?
  Dimitrios Schizas, Michail Vailas, Maria Sotiropoulou, Ioannis A. Ziogas, Konstantinos S. Mylonas, Ioannis Katsaros, Alkistis Kapelouzou, Theodore Liakakos
  Cirugía Española.2021; 99(7): 490.     CrossRef
• Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence?
  Dimitrios Schizas, Michail Vailas, Maria Sotiropoulou, Ioannis A. Ziogas, Konstantinos S. Mylonas, Ioannis Katsaros, Alkistis Kapelouzou, Theodore Liakakos
  Cirugía Española (English Edition).2021; 99(7): 490.     CrossRef
• The role of surgical treatment in isolated organ recurrence of esophageal cancer—a systematic review of the literature
  Dimitrios Schizas, Ioannis I. Lazaridis, Demetrios Moris, Aikaterini Mastoraki, Lazaros-Dimitrios Lazaridis, Diamantis I. Tsilimigras, Nikolaos Charalampakis, Theodore Liakakos
  World Journal of Surgical Oncology.2018;[Epub]     CrossRef
• Esophageal Cancer with Solitary Renal Metastasis Treated with Multidisciplinary Therapy: A Case Report and Mini Review of the Literature
  Kyoung Sik Nam, Kyoungwon Jung, Moo In Park, Seun Ja Park, Won Moon, Sung Eun Kim, Jae Hyun Kim
  The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(1): 39.     CrossRef
• Esophageal Cancer Metastases to Unexpected Sites: A Systematic Review
  Osama Shaheen, Abdulaziz Ghibour, Bayan Alsaid
  Gastroenterology Research and Practice.2017; 2017: 1.     CrossRef
• FDG PET/CT in 2 Cases of Renal Metastasis From Esophageal Squamous Cell Carcinoma
  Qian Zhao, Aisheng Dong, Bo Yang, Yang Wang, Changjing Zuo
  Clinical Nuclear Medicine.2017; 42(11): 896.     CrossRef
• Solitary renal metastasis of esophageal squamous cell carcinoma mimicking primary renal neoplasm – A case report and literature review
  Kai-Po Chang, Chi-Ping Huang, Han Chang
  BioMedicine.2016;[Epub]     CrossRef
• Unilateral renal metastases after definitive chemoradiation in squamous cell carcinoma of esophagus: A case report and review literature
  Kapil Dev, Jaiprakash Gurawalia, Sandeep Nayak, Balu Sadasivan
  Asian Journal of Oncology.2016; 02: 046.     CrossRef
• Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review
  Yan Sun, Xinmin Yu, Yiping Zhang
  World Journal of Surgical Oncology.2014;[Epub]     CrossRef
• Esophageal Adenocarcinoma with Solitary Renal Metastasis
  Thomas D. Willson, Matthew J. Blecha, Mark M. Connolly, Francis J. Podbielski
  Journal of Gastrointestinal Cancer.2013; 44(3): 351.     CrossRef
• Synchronous Squamous Cell Carcinomas of the Esophagus and Renal Pelvis
  Te-Chun Hsieh, Yu-Chin Wu, Shung-Shung Sun, I-Ping Chiang, Chun-Fan Yang, Kuo-Yang Yen, Chia-Hung Kao
  Clinical Nuclear Medicine.2011; 36(11): e171.     CrossRef